Skip to main content
. 2021 Sep 1;12:700570. doi: 10.3389/fimmu.2021.700570

Figure 4.

Figure 4

Gut microbial community structure of AS patients before treatment with different responses to Adalimumab. (A, B) α-diversity; (C) PCoA based on unweighted UniFrac distance. (D) Relative abundance of Comamonas in response and no_response subgroups. AS, ankylosing spondylitis; PCoA, principal coordinates analysis.